BCM
ARNA

BlueCrest Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

BlueCrest Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,151
Closed -$467K – 1584
2018
Q3 		$467K Buy
+10,151
New +$411K 0.01% 790
2017
Q2 		– Sell
-1,712
Closed -$25K – 1172
2017
Q1 		$25K Buy
+1,712
New +$25.4K ﹤0.01% 715

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlueCrest Capital Management's ARNA Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2018, closing a stake of 10,151 shares — an estimated $467K sold.

BlueCrest Capital Management first reported a position in ARNA in Q1 2017 and held it in 2 quarters. The position peaked at $467K in Q3 2018. 177 funds tracked by Wall St. Rank hold ARNA as of Q4 2018.

  • BlueCrest Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 10,151 Arena Pharmaceuticals Inc shares in Q4 2018, an estimated $467K.
  • BlueCrest Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2017 and held it in 2 quarters.
  • BlueCrest Capital Management's Arena Pharmaceuticals Inc position peaked at $467K in Q3 2018.
  • 177 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.